Compound Detail
CHEMBL476960
VOGLIBOSE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL476960 |
| Name | VOGLIBOSE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | FZNCGRZWXLXZSZ-CIQUZCHMSA-N |
7
Targets
34
Activities
1
Assay Types
0
PK Parameters
20
Publications
5
Known Names
2
Indications
1
Mechanisms
Molecular Properties
267.3
MW (Da)
-4.49
ALogP
8
HBA
8
HBD
153.6
PSA (Ų)
0.25
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1994 |
| Availability | Unknown |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Alpha glucosidase inhibitor | INHIBITOR | Alpha glucosidase | ✓ | ✓ |
Indications
Diabetes Mellitus Diabetes Mellitus, Type 2
ATC Classification
A10BF03
voglibose
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: DRUGS USED IN DIABETES
Activity Summary
IC50 34 meas. best 7.16
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Lysosomal alpha-glucosidase CHEMBL2608 | IC50 | 7.16 | 6.205 | 70.0 | 2 |
| Sucrase-isomaltase, intestinal CHEMBL3114 | IC50 | 7.16 | 6.1669 | 70.0 | 16 |
| Acidic alpha-glucosidase CHEMBL3513 | IC50 | 6.96 | 6.5013 | 110.0 | 8 |
| Maltase-glucoamylase CHEMBL2074 | IC50 | 5.89 | 5.89 | 1300.0 | 2 |
| Alpha-glucosidase CHEMBL5291954 | IC50 | 4.83 | 4.83 | 14700.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.63 | 4.63 | 23400.0 | 1 |
| Glycogen debranching enzyme CHEMBL5273 | IC50 | 4.16 | 4.16 | 70000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36812150 | 10.1021/acs.jmedchem.2c01984 | Rattus norvegicus | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 24973028 | 10.1016/j.bmcl.2014.06.001 | Sucrase-isomaltase, intestinal | 2 |
| 23106358 | 10.1021/jm301304e | Sucrase-isomaltase, intestinal | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 21454075 | 10.1016/j.bmcl.2011.02.109 | Sucrase-isomaltase, intestinal | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 21420866 | 10.1016/j.bmc.2011.02.028 | Sucrase-isomaltase, intestinal | 2 |
| 21345683 | 10.1016/j.bmc.2011.01.052 | Sucrase-isomaltase, intestinal | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 21185187 | 10.1016/j.bmcl.2010.11.112 | Sucrase-isomaltase, intestinal | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 39291031 | 10.1021/acsmedchemlett.4c00190 | Alpha-glucosidase | 2 |
| 18595718 | 10.1016/j.bmc.2008.06.026 | Lysosomal alpha-glucosidase | 2 |
| 18595718 | 10.1016/j.bmc.2008.06.026 | Sucrase-isomaltase, intestinal | 2 |
Data from ChEMBL 36 via Core Engine